Portfolio (Quarterly)
Guide ↗
MPM BIOIMPACT LLC
· CIK 0001687078| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | — | DBV Technologies S A | — | 5,213,361.0 | $108.9M | 8.41% | +4.2M | +423.0% | $20.89 | — |
| 2 | CGEM | Cullinan Therapeutics, Inc. | Healthcare | 7,648,268.0 | $108.7M | 8.39% | — | — | $14.21 | -1.6% |
| 3 | AKTS | Aktis Oncology, Inc. | Healthcare | 4,835,872.0 | $86.5M | 6.68% | NEW | — | $17.89 | +6.9% |
| 4 | LQDA | Liquidia Corporation | Healthcare | 1,405,158.0 | $53.0M | 4.09% | — | — | $37.74 | +64.2% |
| 5 | ALMS | Alumis Inc | Healthcare | 2,386,529.0 | $52.6M | 4.06% | -15K | -0.6% | $22.03 | +0.6% |
| 6 | EWTX | Edgewise Therapeutics Inc | Healthcare | 1,660,696.0 | $52.3M | 4.04% | — | — | $31.50 | +3.8% |
| 7 | RVMD | Revolution Medicines, Inc. | Healthcare | 506,776.0 | $49.3M | 3.81% | — | — | $97.25 | +54.6% |
| 8 | AGIO | Agios Pharmaceuticals Inc | Healthcare | 1,306,261.0 | $44.2M | 3.41% | — | — | $33.83 | -14.9% |
| 9 | CORT | Corcept Therapeutics, Inc. | Healthcare | 985,700.0 | $39.7M | 3.07% | NEW | — | $40.31 | +48.1% |
| 10 | TRVI | Trevi Therapeutics Inc | Healthcare | 3,298,430.0 | $39.4M | 3.04% | — | — | $11.93 | +16.3% |
| 11 | DNTH | Dianthus Therapeutics Inc | Healthcare | 423,982.0 | $35.6M | 2.75% | NEW | — | $83.92 | +6.8% |
| 12 | XENE | Xenon Pharmaceuticals Inc | Healthcare | 588,706.0 | $34.2M | 2.64% | +103K | +21.2% | $58.15 | -6.0% |
| 13 | MLTX | MoonLake Immunotherapeutics | Healthcare | 1,811,082.0 | $33.8M | 2.61% | NEW | — | $18.64 | -0.9% |
| 14 | TVTX | Travere Therapeutics Inc | Healthcare | 1,133,365.0 | $33.7M | 2.60% | NEW | — | $29.71 | +46.4% |
| 15 | EVMN | Evommune Inc | Healthcare | 1,455,863.0 | $33.5M | 2.58% | +1.3M | +1188.1% | $22.99 | +2.4% |
| 16 | CYTK | Cytokinetics Inc | Healthcare | 500,000.0 | $33.0M | 2.54% | NEW | — | $65.91 | +18.4% |
| 17 | SNDX | Syndax Pharmaceuticals Inc | Healthcare | 1,340,733.0 | $31.3M | 2.42% | — | — | $23.36 | -13.8% |
| 18 | CNTX | Context Therapeutics Inc | Healthcare | 10,679,391.0 | $28.0M | 2.16% | — | — | $2.62 | -8.4% |
| 19 | — | Forte Biosciences, Inc. | — | 1,000,682.0 | $25.9M | 2.00% | NEW | — | $25.90 | — |
| 20 | PVLA | Palvella Therapeutics Inc | Healthcare | 206,404.0 | $25.7M | 1.99% | — | — | $124.65 | -7.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%